Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 14/20 | 1.00 |
| ▸ | BCHE | P06276 | 14/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL3597256 | 1.00 | BCHE (1.00) | BCHEACHE | |
| Bromide SCHEMBL18154062 | 1.00 | BCHE (1.00) | BCHEACHE | |
| Bromide SCHEMBL4891809 | 1.00 | BCHE (1.00) | BCHEACHE | |
| Bromide SCHEMBL3599912 | 1.00 | BCHE (1.00) | BCHEACHE | |
| Bromide SCHEMBL18154038 | 0.98 | BCHE (0.96) | BCHEACHE | |
| Bromide SCHEMBL14937456 | 0.98 | BCHE (1.00) | BCHEACHE | |
| SCHEMBL4887020 | 0.98 | BCHE (1.00) | BCHEACHE | |
| SCHEMBL3596114 | 0.98 | BCHE (1.00) | BCHEACHE | |
| SCHEMBL3604422 | 0.98 | BCHE (1.00) | BCHEACHE | |
| SCHEMBL3603725 | 0.98 | BCHE (1.00) | BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180135187-A1 | Corrosion Inhibition | SCHLUMBERGER TECHNOLOGY CORPORATION | 2018-05-17 | — | — | US | disclosed |
| WO-2016167837-A1 | CORROSION INHIBITION | SCHLUMBERGER CANADA LIMITED (CA) | 2016-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180135187-A1 | Corrosion Inhibition | SOD1, AOC1, NOX1 | ACHE 837/4885BCHE 3671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.